Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

CUSIP: 08205P209

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class
Equity / Common Stock, par value $0.0001
Total 13F shares
18,997,897
Total 13F value
$240,166,135
Holder snapshot 6 signals
Share change
+5,072,874
SEC-reported price per share
$12.63
Number of holders
30
Value change
+$64,576,294
Number of buys
22
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,393,481

Security key

08205P209

Report period

Q4 2024

Institutions

30

Top holders

10

BNTC full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 Benitec Biopharma Inc. SEC filings Benitec Biopharma Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HBM Healthcare Investment...
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G 13F Lead comparable stake: 4.5% 13D/G row: HBM Healthcare Investments (Cayman) Ltd. Showing 1-6 of 15 holder rows.

Quick read

HBM Healthcare Investments (Cayman) Ltd. leads the comparable SEC ownership view at 4.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HBM Healthcare Investments (Cayman) Ltd.'s linked filing trail.
Comparable ownership Top 5
HBM Healthcare Investments (Cayma... 4.5%
SUVRETTA CAPITAL MANAGEMENT, LLC 25%
JANUS HENDERSON GROUP PLC 2.5%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.4%
Nantahala Capital Management, LLC 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HBM Healthcare Investments (Cayman) Ltd.
13D/G
13D/G
4.5%
$14,156,282
1,041,669 shares
 $0 31 Dec 2024
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
25%
$81,138,997
8,829,053 shares
 — 30 Sep 2024
JANUS HENDERSON GROUP PLC
13F
Company
13F
2.5%
$8,033,333
876,523 shares
 — 30 Sep 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
2.4%
$7,732,420
841,395 shares
 — 30 Sep 2024
Nantahala Capital Management, LLC
13F
Company
13F
2.4%
$7,702,093
838,095 shares
 — 30 Sep 2024
FRANKLIN RESOURCES INC
13F
Company
13F
2.3%
$8,093,903
796,644 shares
 — 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
30
Shares
18,997,897
Rows available
30
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
25
Q4 2024 holders
30
Holder diff
5
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .